Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ryan S. Teller"'
Autor:
Yongchao Su, Ryan S. Teller, Wei Xu, Varsolona Richard J, Daniel Skomski, Seth P. Forster, Stephanie E. Barrett, Jingtao Zhang
Publikováno v:
Molecular Pharmaceutics. 17:2874-2881
The emergence of new active pharmaceutical ingredient (API) polymorphs in pharmaceutical development presents significant risks. Even with thorough polymorph screening, new pathways toward alternate crystal phases can present themselves over the cour
Autor:
Graciela Terife, Ryan S. Teller, David White, Ashley R. Johnson, Michael Lowinger, Stephanie E. Barrett, Seth P. Forster
Publikováno v:
Expert opinion on drug delivery. 18(5)
Introduction: Drug eluting implants offer patient convenience and improved compliance through less frequent dosing, eliminating repeated, painful injections and providing localized, site specific d...
Autor:
Alena Bensussan, Roy Helmy, Bindesh Shrestha, Hernando J. Olivos, Vivek Shah, Elizabeth E. Pierson, William P. Forrest, Ryan S. Teller, Anthony J. Midey, Seth P. Forster
Publikováno v:
Pharmaceutical Research. 37
Desorption electrospray ionization mass spectrometry imaging (DESI-MSI) coupled with gas-phase ion mobility spectrometry was used to characterize the drug distribution in polymeric implants before and after exposure to accelerated in vitro release (I
Autor:
Amy C. Doty, Seth P. Forster, Christopher T. John, Wei Xu, Daniel Skomski, Ryan S. Teller, Stephanie E. Barrett, Yongchao Su, Zhen Liu
Publikováno v:
Journal of pharmaceutical sciences. 109(9)
In pharmaceutical development alternative drug delivery modalities are being increasingly employed. One example is an implant, which achieves gradual drug release in patients over a period of many months or years. Due to the complexity of these long-
Autor:
Jining Zhang, Priya Srinivasan, Betsy C. Herold, Patrick F. Kiser, Chuong Dinh, James M. Smith, Ryan S. Teller, Janet M. McNicholl
Publikováno v:
Journal of Medical Primatology. 46:129-136
Background Intravaginal rings (IVR) for HIV prevention will likely be used by women on depot medroxyprogesterone acetate (DMPA) hormonal contraception. We used pigtailed macaques to evaluate the effects of DMPA on tenofovir disoproxil fumarate (TDF)
Autor:
Megan A. Mackey, Takayuki Tsuchiya, Marian E. Gindy, Steven J. Henry, Li Li, Zhen Yang, Gregory J. Doto, Ryan S. Teller, Lee J. Klein, Stephanie E. Barrett, Michael P. Ruth, Seth P. Forster
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 136
Alternative formulations of entecavir, a once daily oral hepatitis B antiretroviral, may improve treatment adherence by patients. We explored the use of biocompatible polymers to control entecavir dissolution in two formats suitable for subcutaneous
Autor:
Igal Szleifer, Patrick F. Kiser, David C. Malaspina, Rachna Rastogi, Justin T. Clark, Ryan S. Teller
Publikováno v:
Journal of Controlled Release. 224:176-183
Intravaginal ring technology is generally limited to releasing low molecular weight species that can diffuse through the ring elastomer. To increase the diversity of drugs that can be delivered from intravaginal rings, we designed an IVR that contain
Autor:
Antong Chen, Roberto Irizarry, Megan A. Mackey, Seth P. Forster, Daniel Skomski, Ryan S. Teller, Li Li
Publikováno v:
Industrial & Engineering Chemistry Research.
This work develops a mechanistic understanding and a simplified model to understand changes in drug release profiles of an active pharmaceutical ingredient in a long-acting parenteral polymer formu...
Autor:
Yongchao Su, Wei Xu, Seth P. Forster, Ryan S. Teller, Andrew T. Francis, Ronald L. Smith, Jesse Kuiper, Timothy Rhodes, Dan Fu, Tai T. Nguyen, Matthew S. Lamm
Publikováno v:
Molecular pharmaceutics. 15(12)
Localized drug delivery systems (DDSs) provide therapeutic levels of drug agent while mitigating side effects of systemic delivery. These systems offer controlled release over extended periods of time making them attractive therapies. Monitoring drug
Autor:
Seth P. Forster, José A. Lebrón, Jay A. Grobler, Ryan S. Teller, Kerry L. Fillgrove, Stephanie E. Barrett, Zhen Yang, Zhen Liu, Bing Lu, Gregory J. Doto, Megan A. Mackey, Li Sun, Sandra L. Wood, Li Li, Rosa I. Sanchez, Marian E. Gindy, Daniel Skomski, Tao Niu
Regimen adherence remains a major hurdle to the success of daily oral drug regimens for the treatment and prevention of human immunodeficiency virus (HIV) infection. Long-acting drug formulations requiring less-frequent dosing offer an opportunity to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adae5b715cb6db226c3e09eb65164dfd
https://europepmc.org/articles/PMC6153840/
https://europepmc.org/articles/PMC6153840/